Oakworth Capital, Inc. Gsk PLC Transaction History

Oakworth Capital, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$38.88 - $45.31 $6,259 - $7,294	-161 Reduced 7.45%	2,000 $88,000
Q2 2021 Jul 20, 2021	SELL	$36.52 - $41.46 $7,304 - $8,292	-200 Reduced 8.47%	2,161 $86,000
Q1 2021 Apr 30, 2021	BUY	$34.27 - $40.01 $71,967 - $84,021	2,100 Added 804.6%	2,361 $84,000
Q4 2020 Feb 12, 2021	SELL	$34.07 - $39.94 $28,278 - $33,150	-830 Reduced 76.08%	261 $10,000
Q3 2020 Nov 09, 2020	BUY	$38.11 - $42.99 $609 - $687	16 Added 1.49%	1,091 $41,000
Q2 2020 Aug 11, 2020	BUY	$37.87 - $43.58 $6,968 - $8,018	184 Added 20.65%	1,075 $44,000
Q3 2019 Nov 13, 2019	SELL	$40.46 - $43.52 $133,598 - $143,703	-3,302 Reduced 78.75%	891 $38,000
Q1 2018 May 09, 2018	SELL	$36.18 - $40.15 $47,612 - $52,837	-1,316 Reduced 23.89%	4,193 $168,000
Q3 2017 Nov 08, 2017	BUY	$39.44 - $41.55 $217,274 - $228,898	5,509	5,509 $222,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Oakworth Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Oakworth Capital, Inc. with notifications on news.